Close Menu

NEW YORK — The HudsonAlpha Institute for Biotechnology said on Monday that one of its postdoctoral researchers has won a $118,335 grant from the National Institutes of Health to continue research into the genetics of Alzheimer's disease.

With the funding, Nicholas Cochran — a senior postdoc in the lab of HudsonAlpha's Richard Myers — aims to study the regulation of the gene that encodes tau, a protein that is abnormally hyperphosphorylated and aggregates in the brains of Alzheimer's disease patients, and how it is influenced by rare variants.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.